Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
about
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndromeTreatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two DecadesCalcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the LiteratureClinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeSuccessful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome.Controversies in the treatment of idiopathic membranous nephropathy.Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy.The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis.Clinical trial of focal segmental glomerulosclerosis in children and young adults.Treatment of idiopathic membranous nephropathy.Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trialsSkimmin, a Coumarin from Hydrangea paniculata, Slows down the Progression of Membranous Glomerulonephritis by Anti-Inflammatory Effects and Inhibiting Immune Complex DepositionManagement of idiopathic membranous nephropathy.Childhood nephrotic syndrome--current and future therapies.Impact of the National Institutes of Health Focal Segmental Glomerulosclerosis (NIH FSGS) clinical trial on the treatment of steroid-resistant FSGS.Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.Mycophenolate mofetil for primary focal segmental glomerulosclerosis: systematic review.Glomerular diseases: membranous nephropathy--a modern viewOverview of current and alternative therapies for idiopathic membranous nephropathy.Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.Focal Segmental Glomerulosclerosis.Optimal management of primary focal segmental glomerulosclerosis in adultsComparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.Rethinking First-Line Immunosuppression for Idiopathic FSGS.What is the role of rituximab in idiopathic membranous nephropathy?The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
P2860
Q24193098-5BCF10AF-DB83-4BAD-AF5A-FEC81976052DQ26752836-8A09B1E2-AE5A-494A-A720-2D55A9A118B4Q30235177-D99E654E-A3FF-4605-ACFF-7A24A24C76A9Q30427819-826DA0BA-7F57-417B-BB46-D2CC1335426FQ33622259-A756F3AE-368F-4342-BFDF-0F3436E6A84CQ34248343-A08A629B-2FFF-49AC-9059-4C2895DCEBD0Q34448821-55B2DF14-1828-4F78-8811-158E8D13D3BCQ34618530-0E95F181-DE83-4736-9BCB-A055FBE7472CQ35837532-26A48262-90A9-4ED0-911B-AF2CC8CF0B48Q36280345-7A6E863D-F7C5-426A-AF64-7B440869B46FQ36583388-E301346B-FD63-4F43-A4C3-21E79F7A3893Q36810470-44E0BBCA-2935-4735-82E6-FEB1061E4CBAQ37108857-EDB12EA4-1241-42B9-B3C1-7183C1889FB9Q37779802-035D10D6-4110-42FB-A9C7-AD6A507DAB9BQ38017937-F497C4A7-F3DB-4F27-B9A2-1B459FE295ABQ38068148-F481DCB2-B849-4B59-88E8-F9098AC36364Q38085054-0D73DCD6-D99F-4F82-962D-CB617CAA8616Q38113310-85E30443-100B-40F3-BC89-AC743F5B7685Q38118221-14142DB2-D65C-42F0-851D-236D54E7D755Q38425865-1A6C6728-644F-4585-99D2-EFFBC35D7746Q38805701-9A5F6DA7-533B-4032-9F02-033CFD39E9C0Q38938623-C4E3D257-8588-4350-B004-C4D7E5777E64Q39331611-02F3C301-BAC8-4349-9F03-F095ADDB4CDEQ41229115-7AB419B0-1C4E-4C2E-9CD2-4D6BA6565F9AQ42954060-8E823F20-4963-4C7D-84D9-1DE163CD8EC3Q45351919-954DD7BD-4897-465E-9E85-53E39947F5DDQ50019614-D5F697F3-2733-46B8-9EFB-5C579D528173
P2860
Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Mycophenolate mofetil or stand ...... erulosclerosis: a pilot study.
@en
Mycophenolate mofetil or stand ...... erulosclerosis: a pilot study.
@nl
type
label
Mycophenolate mofetil or stand ...... erulosclerosis: a pilot study.
@en
Mycophenolate mofetil or stand ...... erulosclerosis: a pilot study.
@nl
prefLabel
Mycophenolate mofetil or stand ...... erulosclerosis: a pilot study.
@en
Mycophenolate mofetil or stand ...... erulosclerosis: a pilot study.
@nl
P2093
P356
P1476
Mycophenolate mofetil or stand ...... erulosclerosis: a pilot study.
@en
P2093
Anirban Ganguli
Harbir S Kohli
Krishan L Gupta
Kusum Joshi
Lakshmanan Senthil Nayagam
Vinay Sakhuja
P304
P356
10.1093/NDT/GFM538
P407
P577
2007-11-07T00:00:00Z